CMS Issues Sweeping End-Of Year Rule on Medicare Advantage and Medicare Part D
Putting Patients First Blog
DECEMBER 9, 2024
Biosimilars and Generics The formulary inclusion of biosimilars and generics is essential in reducing the costs of medications for Medicare recipients. To enable lower cost medications, CMS would require that plan formularies prioritize access to biosimilars, generics, and affordable other alternatives.
Let's personalize your content